ALFRED E MANN FOUNDATION FOR SCIENTIFIC RESEARCH: Form 990, tax year 2019

View the entire original 990 at ProPublica ↗

Organization
ALFRED E MANN FOUNDATION FOR SCIENTIFIC RESEARCH (EIN 95-4002032)
Tax period
2019-04-01 to 2020-03-31
Filed
2020-07-24
IRS object ID
202042069349300714
Schema version
2019v5.1
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2020-07-24T11:21:55-05:00ReturnTs
Tax Period End2020-03-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN910189318PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1MOSS ADAMS LLPBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line110960 WILSHIRE BLVD SUITE 1100AddressLine1Txt
CityLOS ANGELESCityNm
State AbbreviationCAStateAbbreviationCd
ZIP90024ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2019-04-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN954002032EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1THE ALFRED E MANN FOUNDATION FORBusinessNameLine1Txt
Business Name Line2SCIENTIFIC RESEARCHBusinessNameLine2Txt
FieldValueIRS element (for citing)
Business Name ControlALFRBusinessNameControlTxt
Phone6617026700PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line125134 RYE CANYON LOOPAddressLine1Txt
CitySANTA CLARITACityNm
State AbbreviationCAStateAbbreviationCd
ZIP91355ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonJOHN PETROVICHPersonNm
Person TitleCEOPersonTitleTxt
Phone6617026700PhoneNum
Signature2020-07-21SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonWENDY CAMPOSPreparerPersonNm
PTINP00448102PTIN
Phone3104770450PhoneNum
Preparation2020-07-21PreparationDt

Filing Security Information FilingSecurityInformation

IP Address IPAddress

FieldValueIRS element (for citing)
I Pv4 Address23.242.64.125IPv4AddressTxt
FieldValueIRS element (for citing)
IP2020-07-21IPDt
IP Tm12:16:31IPTm
IP TimezonePDIPTimezoneCd
Filing License TypePFilingLicenseTypeCd
At Submission Creation Device IdDA39A3EE5E6B4B0D3255BFEF95601890AFD80709AtSubmissionCreationDeviceId
At Submission Filing Device Id7D0D6C7A6A5655B0595BBDB8C4257A6B648F0CEBAtSubmissionFilingDeviceId
FieldValueIRS element (for citing)
Tax2019TaxYr
Build TS2020-11-19 02:30:22ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerJOHN PETROVICHPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line125134 RYE CANYON LOOPAddressLine1Txt
CitySANTA CLARITACityNm
State AbbreviationCAStateAbbreviationCd
ZIP91355ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$9,491,255GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website AddressWWW.AEMF.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1985FormationYr
Legal Domicile StateCALegalDomicileStateCd
Activity Or MissionCONDUCT MEDICAL AND SCIENTIFIC RESEARCHActivityOrMissionDesc
Contract TerminationYes (X)ContractTerminationInd
Voting Members Governing Body6VotingMembersGoverningBodyCnt
Voting Members Independent5VotingMembersIndependentCnt
Total Employee37TotalEmployeeCnt
Total Volunteers0TotalVolunteersCnt
Total Gross UBI$24,238TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$5,946NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$680PYContributionsGrantsAmt
CY Contributions Grants$936CYContributionsGrantsAmt
PY Program Service Revenue$280,372PYProgramServiceRevenueAmt
CY Program Service Revenue$887,240CYProgramServiceRevenueAmt
PY Investment Income-$95,738PYInvestmentIncomeAmt
CY Investment Income-$104,857CYInvestmentIncomeAmt
PY Other Revenue$149,392PYOtherRevenueAmt
CY Other Revenue$1,529,155CYOtherRevenueAmt
PY Total Revenue$334,706PYTotalRevenueAmt
CY Total Revenue$2,312,474CYTotalRevenueAmt
PY Grants And Similar Paid$5,000PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$5,000CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$5,452,908PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$9,341,164CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$0CYTotalFundraisingExpenseAmt
PY Other Expenses$2,583,231PYOtherExpensesAmt
CY Other Expenses$4,512,944CYOtherExpensesAmt
PY Total Expenses$8,041,139PYTotalExpensesAmt
CY Total Expenses$13,859,108CYTotalExpensesAmt
PY Revenues Less Expenses-$7,706,433PYRevenuesLessExpensesAmt
CY Revenues Less Expenses-$11,546,634CYRevenuesLessExpensesAmt
Total Assets BOY$93,529,351TotalAssetsBOYAmt
Total Assets EOY$59,071,014TotalAssetsEOYAmt
Total Liabilities BOY$7,095,338TotalLiabilitiesBOYAmt
Total Liabilities EOY$11,490,776TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$86,434,013NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$47,580,238NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionTHE ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH IS A MEDICAL RESEARCH ORGANIZATION DEDICATED TO DEVELOPING AND COMMERCIALIZING INNOVATIVE SOLUTIONS FOR SIGNIFICANT UNMET MEDICAL CONDITIONS.MissionDesc
Significant New Program Srvc0SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
Expense$1,754,859ExpenseAmt
Grant$5,000GrantAmt
Revenue$306,131RevenueAmt
DescIMPLANTABLE MYOELECTRIC SENSOR II (INFINITY) + OSSURTHE INITIAL IMES COLLABORATION WAS RE-VITALIZED TO COMMENCE RESEARCH AND DEVELOPMENT WORK ON A SECOND GENERATION OF IMES, WHICH WILL CONTAIN ADVANCED FEATURES BASED ON PATIENT FEEDBACK RECEIVED FORM THE IMES I CLINICAL TRIAL. THESE FEATURES ARE INTENDED TO IMPROVE MEDICAL OUTCOMES AT NO ADDITIONAL COST TO THE PATIENT OR HEALTHCARE SYSTEM. THE TECHNOLOGY HAS BEEN LICENSED TO OSSUR AND IS IN DESIGN TRANSFER.STATUS: ADDITIONAL ANALYSIS AND DEVELOPMENT WORK WAS DONE TO PREDICT FEASIBILITY OF THE USE OF THE DEVICE ON LOWER LIMBS; THE PRODUCT WAS TRANSFERRED TO A COMMERCIAL PARTNER (OSSUR) INCLUDING DOCUMENTATION OF ALL ELEMENTS OF THE UPPER LIMB PRODUCT; BUILD OF INITIAL CLINICAL IMES INFINITY UNITS WAS STARTED AT THE FOUNDATION; EVALUATION WAS DONE ON POTENTIAL APPROACHES TO REGULATORY APPROVAL WITHIN THE US AND POTENTIALLY IN EUROPE.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$1,504,687ExpenseAmt
Grant$0GrantAmt
Revenue$0RevenueAmt
DescSLEEP APNEA AMF IS INVESTIGATING THE NEED FOR NEWER METHODS TO TREAT OSA (OBSTRUCTIVE SLEEP APNEA). OSA IS AN UNDER-DIAGNOSED AND UNDER-TREATED MEDICAL CONDITION THAT HAS BEEN LINKED TO SEVERAL SERIOUS CO-MORBIDITIES, INCLUDING HEART DISEASE. CURRENT TREATMENT OPTIONS ARE POORLY TOLERATED AND WHEN ADOPTED, HAVE LOW COMPLIANCE RATES. THE AIM OF THE AMF PROGRAM IS TO DEVELOP A NEUROSTIMULATION SYSTEM THAT WILL IMPROVE MEDICAL OUTCOMES AT A LOWER COST THAN CURRENTLY AVAILABLE TREATMENT OPTIONS, WHILE SOLVING THE PATIENT COMPLIANCE ISSUE. SUCH A PRODUCT SYSTEM WILL CONSIST OF A FULLY IMPLANTABLE NEURAL STIMULATOR SENSOR, CLOSED LOOP SYSTEM WITH SEAMLESS OPERATION REQUIRING MINIMAL INTERACTION FROM A PATIENT, THEREBY OFFERING A HIGHER LEVEL OF PATIENT SATISFACTION AND ADOPTION.STATUS:A NEW MECHANICAL DESIGN WAS DEVELOPED AND BUILT INTO DEMO UNITS; PROTOTYPE ELECTRONICS CIRCUITY FOR DEMONSTRATION PURPOSES HAS BEEN DEVELOPED AND BUILT INTO FORM FACTOR UNITS; DEMONSTRATION SOFTWARE WAS DEVELOPED TO DISPLAY RESPIRATION DATA ON A TABLET COMPUTER; ADDITIONAL DISCUSSIONS HELD WITH POTENTIAL COMMERCIAL PARTNERS IN AN EFFORT TO OBTAIN FUNDINGDesc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Expense$7,404,150ExpenseAmt
Grant$0GrantAmt
Revenue$1,855,266RevenueAmt
DescNEW PROJECT DEVELOPMENT AND PROTECTIONTHIS PROGRAM COVERS (A) THE MONITORING AND EVALUATION OF SEVERAL EARLY STAGE ADVANCED RESEARCH AND DEVELOPMENT EFFORTS UNDERWAY THAT ARE DIRECTED AT DEVELOPING ADVANCED TECHNOLOGIES, PROJECT IDEAS AND CONCEPTS BEFORE THEY ARE ELEVATED TO THE STATUS OF FULL-FLEDGED DEVELOPMENT PROGRAMS, AND (B) ONGOING EFFORTS RELATED TO THE ADVANCEMENT OF COMMERCIAL DEVELOPMENT AND PROTECTION OF INTELLECTUAL PROPERTY OF THESE PROJECTS FROM THE TIME THEY ARE ELEVATED TO DEVELOPMENT PROGRAMS AND CONTINUING SOMETIMES UNTIL LONG AFTER THESE PROJECTS HAVE BEEN LAUNCHED INTO SPINOUT COMPANIES OR LICENSED TO COMMERCIAL ENTITIES. THE TEAM COMPRISES THE FULL RANGE OF EXPERTISE AVAILABLE AT AMF, INCLUDING SENIOR EXECUTIVE MANAGEMENT, RESEARCH SCIENTISTS AND ENGINEERS, LEGAL AND INTELLECTUAL PROPERTY EXPERTS, BUSINESS STRATEGISTS AND ANALYSTS. EXPENSES MAY INCLUDE ONGOING PARTICIPATION IN THE DEVELOPMENT EFFORT INCLUDING RESEARCH AND DEVELOPMENT SUPPORT, COLLABORATION MANAGEMENT, SERVICE IN MANAGEMENT OR ON THE BOARD OF DIRECTORS OF SPINOUT ENTITIES, PATENT PROSECUTION AND THE PROSECUTION OF INFRINGEMENT ACTIONS TO PROTECT THE VALUE OF THE INTELLECTUAL PROPERTY WE CREATE. IN ADDITION TO PAYROLL EXPENSES AND DIRECT EXPENSES PAID TO OUTSIDE VENDORS FOR GOODS AND SERVICES RELATED TO PROJECTS, EXPENSES IN THIS PROGRAM MAY INCLUDE PATENT PROSECUTION EXPENSES AND FEES, LEGAL FEES (FOR INTERNAL AND OUTSIDE LEGAL COUNSEL) FOR LITIGATION EXPENSES TO CREATE, PRESERVE AND PROTECT INTELLECTUAL PROPERTY FROM INFRINGEMENT AND REMEDY PAST INFRINGEMENT, AND INCENTIVE AND OTHER COMPENSATION PAYMENTS TO EMPLOYEES AND OTHERS RELATED TO THESE PROGRAMS AND ACTIONS. DEPENDING ON FACTS AND CIRCUMSTANCES, IN SOME CASES CERTAIN OF THESE EXPENDITURES MIGHT BE INCURRED LONG AFTER THE PROJECTS HAVE BEEN LAUNCHED INTO SPINOUT COMPANIES OR LICENSED TO THIRD PARTIES.REVENUES ASSOCIATED WITH THESE PROJECTS (SOME OF WHICH MAY ACCRUE LONG AFTER THE PROJECT AND ANY RELATED PROGRAM HAVE BEEN OUT-LICENSED OR LAUNCHED INTO A SPINOUT COMPANY) MAY INCLUDE RECOVERIES OF JUDGMENTS OR SETTLEMENTS FROM PATENT INFRINGEMENT LITIGATION, ROYALTIES ON NET SALES OF LICENSED PRODUCTS, MILESTONE PAYMENTS, ONGOING CONTRACT R&D FROM PARTNERS, LICENSEES AND SPINOUT COMPANIES, INTEREST, AND PROCEEDS OF LIQUIDITY EVENTS (E.G., INITIAL PUBLIC OFFERINGS, ACQUISITIONS) INVOLVING RETAINED EQUITY INTERESTS IN PROJECTS THAT HAVE BEEN SPUN OUT INTO STARTUP COMPANIES. STATUS:MAJOR EFFORTS WERE MADE IN THIS AREA RESULTING IN A NUMBER OF NEW POTENTIAL PROJECTS; OVER 40 POTENTIAL INDICATIONS WERE REVIEWED TO FOCUS IN ON A SMALL NUMBER OF KEY AREAS WITH DEVELOPMENT POTENTIAL; FURTHER ANALYSIS WAS PERFORMED ON THIS SUBSET AND PRIORITIES WERE SET FOR EACH OF THE FINALISTS; INCENTIVE COMPENSATION PAYMENTS WERE ISSUED TO PARTICIPANTS IN A LONG-TERM INCENTIVE PLAN RELATED TO A LIQUIDITY EVENT ASSOCIATED WITH A PROJECT LAUNCHED IN 2013; LEGAL EXPENSES CONTINUED TO BE ACCRUED IN CONNECTION WITH ONGOING PATENT INFRINGEMENT LITIGATION RELATING TO COCHLEAR IMPLANT INTELLECTUAL PROPERTY OWNED BY AMFDesc

Prog Srvc Accom Acty Other ProgSrvcAccomActyOtherGrp (2 entries)

ExpenseExpenseAmtGrantGrantAmtRevenueRevenueAmtDescDesc
$367,364$0$254,998ORION TMTHE FOUNDATION IS SUPPORTING THE DEVELOPMENT OF A NEW GROUNDBREAKING VISUAL CORTICAL PROSTHESIS THAT WILL ENABLE THE PARTIAL RESTORATION OF VISION TO HUNDREDS OF THOUSANDS OF PATIENTS IN THE US SUFFERING FROM DISORDERS SUCH AS DIABETIC RETINOPATHY, GLAUCOMA, OR TRAUMA TO THE EYES OR OPTIC NERVE. IT IS A FULLY-IMPLANTABLE, NEURAL-INTERFACE SYSTEM CAPABLE OF ELECTRICALLY STIMULATING THE HUMAN VISUAL CORTEX AND RESTORING VISUAL PERCEPTION TO PROFOUNDLY BLIND PATIENTS WHO TODAY HAVE NO OTHER TREATMENT OPTIONS. THIS HIGH-DENSITY CORTICAL STIMULATION PROSTHESIS, CALLED THE ORION TM, HAS AN ARRAY SPECIFICALLY DESIGNED FOR THE VISUAL CORTEX. THE GOAL OF THIS PROJECT IS TO FINALIZE THE DESIGN OF THE CORTICAL PROSTHESIS THROUGH AN IDE EARLY FEASIBILITY HUMAN CLINICAL TRIAL. STATUS:INITIAL CLINICAL TRIAL RESULTS IN THE FIRST PATIENTS ARE VERY POSITIVE; THE FOUNDATION HAS BEEN KEY IN THE PROGRAM MANAGEMENT BY PROVIDING ONE OF THE PRINCIPLE INVESTIGATORS; IN ADDITION, THE FOUNDATION HAS BEEN SUPPORTING VARIOUS MECHANICAL AND ELECTRICAL ENGINEERING ACTIVITIES; FOUNDATION MAY INCREASE SUPPORT LEVEL FOR THE PROGRAM
$151,988$0$0IMPLANTABLE DRUG PUMPTHE IMPLANTABLE DRUG PUMP (IDP) PROGRAM WAS ONCE AN INTERNAL AMF PROGRAM THAT WAS SPUN OUT INTO A FOR-PROFIT SUBSIDIARY, MEDALLION THERAPEUTICS, INC. THAT FOR PROFIT EFFORT WAS NOT SUCCESSFUL, LEADING AMF TO CEASE OPERATIONS OF THIS SUBSIDIARY, WIND DOWN THE BUSINESS, AND BRING BACK INTO AMF ALL INTELLECTUAL PROPERTY AND OTHER ASSETS RELATING TO THE IDP, ALL OF WHICH OCCURRED IN LATE 2019. SINCE THAT TIME, AMF HAS CONTINUED TO SEARCH FOR SUITABLE PARTNERS TO DEVELOP THE IDP FURTHER IN CERTAIN FIELDS OF USE REQUIRING DRUG DELIVERY FOR CHRONIC CONDITIONS. THE IDP IS A SOPHISTICATED, HIGHLY PROGRAMMABLE DRUG INFUSION DEVICE THAT IS IMPLANTED IN THE ABDOMEN AND REFILLED VIA A HYPODERMIC NEEDLE THROUGH THE SKIN. INFUSION RATES AND SCHEDULES MAY BE PROGRAMMED, AND VIA VARIOUS FORMS OF CATHETERS, DRUGS CAN BE DELIVERED INTRATHECALLY TO THE SPINAL COLUMN, INTO THE ABDOMEN, INTO THE BRAIN, OR INTRAVENOUSLY. STATUS: SEVERAL DISCUSSIONS HAVE BEEN INITIATED DIRECTED TOWARDS LICENSING AND COMMERCIALIZING THE IDP IN SEVERAL FIELDS OF USE; AMF HAS EXPLORED AND APPLIED FOR MULTIPLE GRANTS TO FURTHER THE DEVELOPMENT OF THE IDP IN THE FIELD OF PAIN; DESIGN UPDATES AND UPGRADES HAVE BEEN CONSIDERED
FieldValueIRS element (for citing)
Total Other Prog Srvc Expense$519,352TotalOtherProgSrvcExpenseAmt
Total Other Prog Srvc Grant$0TotalOtherProgSrvcGrantAmt
Total Other Prog Srvc Revenue$254,998TotalOtherProgSrvcRevenueAmt
Total Program Service Expenses$11,183,048TotalProgramServiceExpensesAmt
Described In Section501c3Yes (1)DescribedInSection501c3Ind
Schedule B Required0ScheduleBRequiredInd
Political Campaign Acty0PoliticalCampaignActyInd
Lobbying Activities0LobbyingActivitiesInd
Subject To Proxy Tax0SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Donor Rstr Or Quasi Endowments0DonorRstrOrQuasiEndowmentsInd
Report Land Building EquipmentYes (1)ReportLandBuildingEquipmentInd
Report Investments Other Sec0ReportInvestmentsOtherSecInd
Report Program Related Invst0ReportProgramRelatedInvstInd
Report Other Assets0ReportOtherAssetsInd
Report Other Liabilities0ReportOtherLiabilitiesInd
Include FIN48 FootnoteYes (1)IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt0IndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtYes (1)ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign Office0ForeignOfficeInd
Foreign ActivitiesYes (1)ForeignActivitiesInd
More Than5000 K To Org0MoreThan5000KToOrgInd
More Than5000 K To Individuals0MoreThan5000KToIndividualsInd
Professional Fundraising0ProfessionalFundraisingInd
Fundraising Activities0FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To Organizations0GrantsToOrganizationsInd
Grants To Individuals0GrantsToIndividualsInd
Schedule J RequiredYes (1)ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Engaged In Excess Benefit Trans0EngagedInExcessBenefitTransInd
PY Excess Benefit Trans0PYExcessBenefitTransInd
Loan Outstanding0LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org Mem0BusinessRlnWithOrgMemInd
Business Rln With Fam Mem0BusinessRlnWithFamMemInd
Business Rln With35 Ctrl Ent0BusinessRlnWith35CtrlEntInd
Deductible Non Cash Contri0DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial LiquidationYes (1)PartialLiquidationInd
Disregarded Entity0DisregardedEntityInd
Related EntityYes (1)RelatedEntityInd
Related Organization Ctrl EntYes (1)RelatedOrganizationCtrlEntInd
Transaction With Control EntYes (1)TransactionWithControlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org0TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
IRP Document24IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (1)BackupWthldComplianceInd
Employee37EmployeeCnt
Employment Tax Returns FiledYes (1)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over LimitYes (1)UnrelatedBusIncmOverLimitInd
Form990 T FiledYes (1)Form990TFiledInd
Foreign Financial Account0ForeignFinancialAccountInd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible Contributions0NondeductibleContributionsInd
Quid Pro Quo Contributions0QuidProQuoContributionsInd
Form8282 Property Disposed Of0Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct0RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct0PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services0IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht Pymt0SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc0SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members6GoverningBodyVotingMembersCnt
Independent Voting Member5IndependentVotingMemberCnt
Family Or Business Rln0FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org DocumentsYes (1)ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or Stockholders0MembersOrStockholdersInd
Election Of Board Members0ElectionOfBoardMembersInd
Decisions Subject To Approva0DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (1)MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local Chapters0LocalChaptersInd
Form990 Provided To Gvrn BodyYes (1)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (1)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (1)WhistleblowerPolicyInd
Document Retention PolicyYes (1)DocumentRetentionPolicyInd
Compensation Process CEOYes (1)CompensationProcessCEOInd
Compensation Process OtherYes (1)CompensationProcessOtherInd
Investment In Joint VentureYes (1)InvestmentInJointVentureInd
Written Policy Or ProcedureYes (1)WrittenPolicyOrProcedureInd
States Where Copy Of Return Is FldCAStatesWhereCopyOfReturnIsFldCd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1FARAH BOROOMANDBusinessNameLine1Txt
FieldValueIRS element (for citing)
Phone6617026731PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line125134 RYE CANYON LOOPAddressLine1Txt
CitySANTA CLARITACityNm
State AbbreviationCAStateAbbreviationCd
ZIP91355ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (21 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtFormer Ofcr Director TrusteeFormerOfcrDirectorTrusteeIndIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndKey EmployeeKeyEmployeeIndHighest Compensated EmployeeHighestCompensatedEmployeeInd
MARK CHAMBERLAIN
CHIEF OPERATING OFFICER42.00Yes (X)$891,918$0$42,519
JOHN PETROVICH
PRESIDENT AND CEO45.00Yes (X)$881,173$0$38,917
FARAH BOROOMAND
CHIEF FINANCIAL OFFICER44.00Yes (X)$812,256$0$42,301
DAVID HANKIN THRU 73117
FORMER CHIEF EXECUTIVE OFFICER0.00$627,628$0$0Yes (X)
ROBERT GREENBERG
CHAIRMAN OF THE BOARD/ EXECUTIVE CHAIRMAN40.00Yes (X)$417,921$0$37,238Yes (X)
MICHAEL PERRIN
VP QUAL. ASSUR., REGULATORY, OPERATIONS39.00$419,457$0$25,922Yes (X)
BRIAN DEARDEN
DIRECTOR, ELECTRICAL ENGINEERING40.00$378,746$0$38,293Yes (X)
JOSEPH CALDERON
DIRECTOR, MECHANICAL ENGINEERING40.00$359,843$0$37,022Yes (X)
GLEN GRIFFITH THRU 12717
FORMER TECHNICAL DIRECTOR0.00$392,967$0$0Yes (X)
SIEGMAR SCHMIDT THRU 12717
FORMER EMERGING TECH. GRP. MGR.0.00$392,268$0$0Yes (X)
VALMA KLEIN
DIRECTOR, CLINICAL RESEARCH43.00$179,182$0$23,591Yes (X)
PHILIP LEE
ASSISTANT GENERAL COUNSEL41.00Yes (X)$161,841$0$29,253
SAM BOWMAN
PRINCIPAL ENGINEER ELECTRICAL40.00$156,404$0$19,502Yes (X)
KAREN MORRIS
SR. DIRECTOR, HR & FACILITIES MGMT.40.00$146,228$0$22,660Yes (X)
XIAODONG YANG
SYSTEMS VALIDATION GROUP MANAGER40.00$143,044$0$23,498Yes (X)
HARSHIT SURI
PRINCIPAL DESIGN ENGINEER40.00$148,957$0$8,982Yes (X)
MARI DANIHEL
BOARD MEMBER2.00$0$0$0Yes (X)
KEN WEATHERWAX
BOARD MEMBER1.50$0$0$0Yes (X)
RICHARD WAUGH
BOARD MEMBER2.00$0$0$0Yes (X)
DAVID GILL STARTED 3302020
BOARD MEMBER0.00$0$0$0Yes (X)
DAVID LONG STARTED 3302020
BOARD MEMBER0.00$0$0$0Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$6,509,833TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$389,698TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K19IndivRcvdGreaterThan100KCnt
Former Ofcr Employees ListedYes (1)FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (1)TotalCompGreaterThan150KInd
Compensation From Other Srcs0CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp

Contractor Name ContractorName

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1COMPUTER PACKAGES INCBusinessNameLine1Txt

Contractor Address ContractorAddress

US Address USAddress

FieldValueIRS element (for citing)
Address Line111 N WASHINGTON STREET SUITE 300AddressLine1Txt
CityROCKVILLECityNm
State AbbreviationMDStateAbbreviationCd
ZIP20850ZIPCd
FieldValueIRS element (for citing)
ServicesPATENT RENEWALSServicesDesc
Compensation$101,352CompensationAmt
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K1CntrctRcvdGreaterThan100KCnt
All Other Contributions$936AllOtherContributionsAmt
Total Contributions$936TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp (3 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtRelated Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt
OTHER PROGRAM REVENUE900099$326,111$326,111
IMES II PROGRAM REVENUE900099$306,131$306,131
RESEARCH GRANT INCOME900099$254,998$254,998
FieldValueIRS element (for citing)
Total Program Service Revenue$887,240TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$120,258TotalRevenueColumnAmt
Unrelated Business Revenue$24,238UnrelatedBusinessRevenueAmt
Exclusion$96,020ExclusionAmt

Royalties Revenue RoyaltiesRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$1,529,155TotalRevenueColumnAmt
Related Or Exempt Func Income$1,529,155RelatedOrExemptFuncIncomeAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$6,953,666SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$5,029,299SecuritiesAmt
Other$2,149,482OtherAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$1,924,367SecuritiesAmt
Other-$2,149,482OtherAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column-$225,115TotalRevenueColumnAmt
Exclusion-$225,115ExclusionAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$2,312,474TotalRevenueColumnAmt
Related Or Exempt Func Income$2,416,395RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$24,238UnrelatedBusinessRevenueAmt
Exclusion-$129,095ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$5,000TotalAmt
Program Services$5,000ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$5,407,904TotalAmt
Program Services$4,077,201ProgramServicesAmt
Management And General$1,330,703ManagementAndGeneralAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$3,059,257TotalAmt
Program Services$2,617,818ProgramServicesAmt
Management And General$441,439ManagementAndGeneralAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$38,885TotalAmt
Program Services$30,239ProgramServicesAmt
Management And General$8,646ManagementAndGeneralAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$481,433TotalAmt
Program Services$405,134ProgramServicesAmt
Management And General$76,299ManagementAndGeneralAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$353,685TotalAmt
Program Services$280,603ProgramServicesAmt
Management And General$73,082ManagementAndGeneralAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$2,220,990TotalAmt
Program Services$2,091,776ProgramServicesAmt
Management And General$129,214ManagementAndGeneralAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$82,550TotalAmt
Program Services$7,165ProgramServicesAmt
Management And General$75,385ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$290,386TotalAmt
Program Services$166,851ProgramServicesAmt
Management And General$123,535ManagementAndGeneralAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$390,255TotalAmt
Program Services$320,210ProgramServicesAmt
Management And General$70,045ManagementAndGeneralAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$129,367TotalAmt
Program Services$86,259ProgramServicesAmt
Management And General$43,108ManagementAndGeneralAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$879,887TotalAmt
Program Services$685,242ProgramServicesAmt
Management And General$194,645ManagementAndGeneralAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$38,169TotalAmt
Program Services$27,372ProgramServicesAmt
Management And General$10,797ManagementAndGeneralAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$14,396TotalAmt
Program Services$7,788ProgramServicesAmt
Management And General$6,608ManagementAndGeneralAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$295,862TotalAmt
Program Services$237,328ProgramServicesAmt
Management And General$58,534ManagementAndGeneralAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$65,836TotalAmt
Program Services$51,280ProgramServicesAmt
Management And General$14,556ManagementAndGeneralAmt

Other Expenses OtherExpensesGrp (2 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmt
MISCELLANEOUS$85,596$70,320$15,276
EDUCATION & MORALE$19,650$15,462$4,188

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$13,859,108TotalAmt
Program Services$11,183,048ProgramServicesAmt
Management And General$2,676,060ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$1,602,272BOYAmt
EOY$868,093EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$294,449BOYAmt
EOY$10,066,791EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$68,434BOYAmt
EOY$8,361EOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

FieldValueIRS element (for citing)
EOY$1,258,458EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$101,460BOYAmt
EOY$92,936EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$8,195,105LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$7,553,934LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$775,444BOYAmt
EOY$641,171EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$319,084BOYAmt
EOY$40,819,608EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

FieldValueIRS element (for citing)
BOY$88,801,381BOYAmt
EOY$2,457,544EOYAmt

Intangible Assets IntangibleAssetsGrp

FieldValueIRS element (for citing)
BOY$916,321BOYAmt
EOY$1,571,358EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$650,506BOYAmt
EOY$1,286,694EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$93,529,351BOYAmt
EOY$59,071,014EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$1,095,338BOYAmt
EOY$3,490,776EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$6,000,000BOYAmt
EOY$8,000,000EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$7,095,338BOYAmt
EOY$11,490,776EOYAmt
FieldValueIRS element (for citing)
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$86,434,013BOYAmt
EOY$47,580,238EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$86,434,013BOYAmt
EOY$47,580,238EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$93,529,351BOYAmt
EOY$59,071,014EOYAmt
FieldValueIRS element (for citing)
Info In Schedule O Part XIYes (X)InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss-$11,546,634ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst$4,880,310NetUnrlzdGainsLossesInvstAmt
Prior Period Adjustments$237,627PriorPeriodAdjustmentsAmt
Other Changes In Net Assets-$32,425,078OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or Review0AccountantCompileOrReviewInd
FS AuditedYes (1)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Consolidated Basis Fincl StmtYes (X)ConsolidatedBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (1)AuditCommitteeInd
Federal Grant Audit Required0FederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Medical Research OrganizationYes (X)MedicalResearchOrganizationInd

Hospital Name And Address HospitalNameAndAddressGrp (2 entries)

CityCityNmState AbbreviationStateAbbreviationCd
WALTER REED NATIONAL MILITARY MEDICAL CENTER
BETHESDAMD
UCLA FOUNDATION
LOS ANGELESCA

Schedule D IRS990ScheduleD

Leasehold Improvements LeaseholdImprovementsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$1,235,890OtherCostOrOtherBasisAmt
Depreciation$713,560DepreciationAmt
Book Value$522,330BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$4,906,175OtherCostOrOtherBasisAmt
Depreciation$4,805,450DepreciationAmt
Book Value$100,725BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$2,053,040OtherCostOrOtherBasisAmt
Depreciation$2,034,924DepreciationAmt
Book Value$18,116BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$641,171TotalBookValueLandBuildingsAmt
Footnote TextYes (X)FootnoteTextInd
Total Rev Etc Audited Fincl Stmt$7,192,784TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst$4,880,310NetUnrealizedGainsInvstAmt
Revenue Not Reported$4,880,310RevenueNotReportedAmt
Revenue Subtotal$2,312,474RevenueSubtotalAmt
Revenue Not Reported Fincl Stmt$0RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$2,312,474TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$13,859,108TotExpnsEtcAuditedFinclStmtAmt
Expenses Not Reported$0ExpensesNotReportedAmt
Expenses Subtotal$13,859,108ExpensesSubtotalAmt
Expenses Not Rpt Fincl Stmt$0ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$13,859,108TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART X, LINE 2:FormAndLineReferenceDesc
ExplanationTHE ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH IS EXEMPT FROM FEDERAL INCOME AND CALIFORNIA FRANCHISE TAXES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE AND THE CORRESPONDING CALIFORNIA PROVISIONS. THE FOUNDATION'S SUBSIDIARIES ARE C CORPORATIONS AND ARE SUBJECT TO FEDERAL INCOME AND CALIFORNIA FRANCHISE TAXES. THE ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH HAD NO SIGNIFICANT UNRELATED BUSINESS INCOME TAX DURING THE YEARS ENDED MARCH 31, 2020 AND 2019. ACCORDINGLY, NO TAX PROVISION FOR UNRELATED BUSINESS INCOME HAS BEEN MADE IN THE ACCOMPANYING CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED MARCH 31, 2020 AND 2019. MEDALLION AND MONOLYTHIX ARE FOR-PROFIT ENTITIES. INCOME TAXES FOR THESE ENTITIES ARE PROVIDED FOR UNDER THE LIABILITY METHOD, AND AS SUCH, DEFERRED INCOME TAXES ARE RECOGNIZED FOR THE TAX CONSEQUENCES OF TEMPORARY DIFFERENCES BY APPLYING ENACTED STATUTORY TAX RATES APPLICABLE TO FUTURE YEARS TO DIFFERENCES BETWEEN THE CONSOLIDATED FINANCIAL STATEMENT CARRYING AMOUNTS AND THE TAX BASIS OF EXISTING ASSETS AND LIABILITIES. A VALUATION ALLOWANCE REDUCES DEFERRED INCOME TAX ASSETS WHEN IT IS MORE-LIKELY-THAN-NOT THAT SOME PORTION OR ALL OF THE DEFERRED INCOME TAX ASSETS WILL NOT BE REALIZED. THE TEMPORARY DIFFERENCES CONSISTED PRIMARILY OF NET OPERATING LOSS CARRY FORWARDS, WHICH EXPIRE ON VARIOUS DATES THROUGH 2026. AT MARCH 31, 2019, MEDALLION AND MONOLYTHIX, SUBSIDIARIES OF THE FOUNDATION, HAD NO DEFERRED TAX ASSETS. DURING THE YEAR ENDED MARCH 31, 2020, THE SUBSIDIARIES OF THE FOUNDATION DISSOLVED. THE FOUNDATION, UNDER THE PROVISIONS OF ASC 740, INCOME TAXES, HAD NO UNCERTAIN TAX POSITIONS REQUIRING ACCRUAL AS OF MARCH 31, 2020 AND 2019.ExplanationTxt

Schedule F IRS990ScheduleF

Account Activities Outside US AccountActivitiesOutsideUSGrp (2 entries)

RegionRegionTxtOfficesOfficesCntEmployeeEmployeeCntType Of Activities ConductedTypeOfActivitiesConductedTxtRegion Total ExpendituresRegionTotalExpendituresAmt
CENTRAL AMERICA AND THE CARIBBEAN00INVESTMENTS$467,914
CENTRAL AMERICA AND THE CARIBBEAN00INVESTMENT FEE EXPENDITURES$120
FieldValueIRS element (for citing)
Subtotal Offices0SubtotalOfficesCnt
Subtotal Employees0SubtotalEmployeesCnt
Continuation Total Office0ContinuationTotalOfficeCnt
Continuation Total Employee0ContinuationTotalEmployeeCnt
Total Office0TotalOfficeCnt
Total Employee0TotalEmployeeCnt
Subtotal Spent$468,034SubtotalSpentAmt
Continuation Spent$0ContinuationSpentAmt
Total Spent$468,034TotalSpentAmt
Transfer To Foreign CorpYes (1)TransferToForeignCorpInd
Interest In Foreign Trust0InterestInForeignTrustInd
Foreign Corp OwnershipYes (1)ForeignCorpOwnershipInd
Passive Foreign Investmest CoYes (1)PassiveForeignInvestmestCoInd
Foreign PartnershipYes (1)ForeignPartnershipInd
Boycott Countries0BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART I, LINE 3:THE ACCRUAL METHOD OF ACCOUNTING IS USED FOR BOTH AMOUNTS REPORTED AS INVESTMENTS AND EXPENDITURES.
PART III ACCOUNTING METHOD:

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Independent ConsultantYes (X)IndependentConsultantInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance Payment0SeverancePaymentInd
Supplemental Nonqual Rtr Plan0SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm0EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org0CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs0CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org0CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs0CompBsdNetEarnsRltdOrgsInd
Any Non Fixed PaymentsYes (1)AnyNonFixedPaymentsInd
Initial Contract Exception0InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (16 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
MARK CHAMBERLAIN
CHIEF OPERATING OFFICER$294,470$0$597,448$0$0$0$5,599$0$36,920$0$934,437$0$0$0
JOHN PETROVICH
PRESIDENT AND CEO$342,147$0$539,026$0$0$0$5,599$0$33,318$0$920,090$0$0$0
FARAH BOROOMAND
CHIEF FINANCIAL OFFICER$247,308$0$564,948$0$0$0$5,599$0$36,702$0$854,557$0$0$0
DAVID HANKIN THRU 73117
FORMER CHIEF EXECUTIVE OFFICER$0$0$627,628$0$0$0$0$0$0$0$627,628$0$0$0
ROBERT GREENBERG
CHAIRMAN OF THE BOARD/ EXECUTIVE CHA$415,921$0$2,000$0$0$0$5,599$0$31,639$0$455,159$0$0$0
MICHAEL PERRIN
VP QUAL. ASSUR., REGULATORY, OPERATI$171,096$0$248,361$0$0$0$3,477$0$22,445$0$445,379$0$0$0
BRIAN DEARDEN
DIRECTOR, ELECTRICAL ENGINEERING$170,212$0$208,534$0$0$0$5,599$0$32,694$0$417,039$0$0$0
JOSEPH CALDERON
DIRECTOR, MECHANICAL ENGINEERING$151,709$0$208,134$0$0$0$5,599$0$31,423$0$396,865$0$0$0
GLEN GRIFFITH THRU 12717
FORMER TECHNICAL DIRECTOR$699$0$392,268$0$0$0$0$0$0$0$392,967$0$0$0
SIEGMAR SCHMIDT THRU 12717
FORMER EMERGING TECH. GRP. MGR.$0$0$392,268$0$0$0$0$0$0$0$392,268$0$0$0
VALMA KLEIN
DIRECTOR, CLINICAL RESEARCH$166,982$0$12,200$0$0$0$3,234$0$20,357$0$202,773$0$0$0
PHILIP LEE
ASSISTANT GENERAL COUNSEL$152,841$0$9,000$0$0$0$3,141$0$26,112$0$191,094$0$0$0
SAM BOWMAN
PRINCIPAL ENGINEER ELECTRICAL$146,404$0$10,000$0$0$0$2,798$0$16,704$0$175,906$0$0$0
KAREN MORRIS
SR. DIRECTOR, HR & FACILITIES MGMT.$141,728$0$4,500$0$0$0$2,826$0$19,834$0$168,888$0$0$0
XIAODONG YANG
SYSTEMS VALIDATION GROUP MANAGER$138,044$0$5,000$0$0$0$2,798$0$20,700$0$166,542$0$0$0
HARSHIT SURI
PRINCIPAL DESIGN ENGINEER$136,957$0$12,000$0$0$0$2,991$0$5,991$0$157,939$0$0$0

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 7FormAndLineReferenceDesc
ExplanationREGULAR ANNUAL BONUSES ARE PAID PURSUANT TO AMF'S ANNUAL INCENTIVE PLAN, WHICH IS REVIEWED, RENEWED AND APPROVED EACH YEAR BY THE BOARD OF DIRECTORS. THESE BONUSES ARE BASED ON ACHIEVEMENT OF PERSONAL AND CORPORATE GOALS, AMONG OTHER CONSIDERATIONS, AND ARE APPROVED BY THE BOARD OF DIRECTORS. ADDITIONALLY, BONUSES WERE PAID THIS YEAR FOR THE FIRST TIME UNDER AN INCENTIVE COMPENSATION PLAN KNOWN AS THE ALFRED MANN FOUNDATION FOR SCIENTIFIC RESEARCH INCENTIVE COMPENSATION PLAN - AXONICS MODULATION TECHNOLOGIES, INC. (THE "PLAN"), AND WAS APPROVED BY THE BOARD OF DIRECTORS EFFECTIVE AS OF APRIL 1, 2014, AS AMENDED AND RESTATED ON AUGUST 3, 2016. THE PLAN IS ALSO REFERRED TO AS A LONG-TERM INCENTIVE PLAN, OR "LTIP". AS STATED IN THE PLAN, "THE PURPOSE OF THE PLAN IS TO ENHANCE THE ABILITY OF AMF TO ATTRACT AND RETAIN HIGHLY QUALIFIED EMPLOYEES BY PROVIDING INCENTIVE COMPENSATION OPPORTUNITIES. TO THE EXTENT THE PLAN PROVIDES FOR A DEFERRAL OF COMPENSATION, THE PLAN IS INTENDED TO BE AN INELIGIBLE DEFERRED COMPENSATION PLAN WITHIN THE MEANING OF SECTION 457(F) OF THE INTERNAL REVENUE CODE OF 1986, AS AMENDED (THE "CODE")." THE PLAN IS INTENDED TO BE A NONQUALIFIED DEFERRED COMPENSATION PLAN WITHIN THE MEANING OF CODE SECTION 457(F), AND AS SUCH PARTICIPATION IS LIMITED TO EMPLOYEES WHO (I) QUALIFY FOR INCLUSION IN A SELECT GROUP OF MANAGEMENT OR HIGHLY COMPENSATED EMPLOYEES" WITHIN THE MEANING OF ERISA SECTIONS 201(2), 301(A)(3) AND 401(A)(1), AND (II) ARE DESIGNATED BY THE COMMITTEE TO BE ELIGIBLE FOR A COMPENSATION AWARD. EMPLOYEES DESIGNATED TO RECEIVE AWARDS ENTER INTO AN INDIVIDUAL AWARD AGREEMENTS UNDER THE PLAN. GENERALLY SPEAKING, AWARDS ARE PAID UPON THE OCCURRENCE OF CERTAIN EVENTS (IN THIS CASE, A LIQUIDITY EVENT, AS DEFINED IN THE AWARD AGREEMENT) RELATING TO STOCK OF AXONICS MODULATION TECHNOLOGIES, INC. OWNED BY AMF (AXONICS IS A FOR-PROFIT SPINOUT COMPANY LAUNCHED IN 2013 BY AMF TO COMMERCIALIZE IMPLANTABLE STIMULATOR TECHNOLOGIES; AXONICS CONSUMMATED AN INITIAL PUBLIC OFFERING OF ITS STOCK IN OCTOBER 2018, TRIGGERING AN AWARD PAYMENT UNDER THE PLAN). AWARDS ARE ALSO PAID UPON THE RECEIPT BY AMF FROM AXONICS OF ROYALTIES UNDER A LICENSE AGREEMENT BETWEEN AMF AND AXONICS COVERING CERTAIN AMF PATENTS AND OTHER INTELLECTUAL PROPERTY LICENSED TO AXONICS. PLAN AWARDS PROVIDE LONG-TERM, DEFERRED INCENTIVE COMPENSATION TO AWARD RECIPIENTS MEANT TO SERVE AS A GENERAL EMPLOYEE RETENTION TOOL, AND ALSO TO REWARD KEY PARTICIPANTS IN THE UNDERLYING PROJECT OR RESEARCH EFFORT THAT WAS THE SUBJECT OF THE LTIP. UPON ACTUAL RECEIPT BY AMF OF PROCEEDS OF A LIQUIDITY EVENT (AND AFTER DEDUCTING CERTAIN AMOUNTS DESIGNED TO REIMBURSE AMF FOR ITS COSTS OF THE UNDERLYING ASSET), AN AWARD POOL IS CREATED AND AWARD RECIPIENTS ARE PAID A PERCENTAGE OF THE NET PROCEEDS RECEIVED BY AMF. TYPICALLY, THE TOTAL AWARDS TO ALL RECIPIENTS IN ANY PLAN DO NOT EXCEED 12.00% OF THE AMOUNT OF NET PROCEEDS REALIZED BY AMF. NO AMOUNTS ARE PAYABLE UNLESS AND UNTIL AMF HAS ACTUALLY RECEIVED THE PROCEEDS OF A LIQUIDITY EVENT OR ROYALTIES UNDER THE LICENSE AGREEMENT. THE AWARDS ARE SUBJECT TO SEVERAL CONDITIONS, DESIGNED TO PROVIDE A SUBSTANTIAL RISK OF FORFEITURE TO THE AWARD RECIPIENT. AMONG THESE CONDITIONS AND RISKS ARE: - THE RISK OF FORFEITURE IF THE RECIPIENT LEAVES THE EMPLOY OF AMF OR IS TERMINATED PRIOR TO VESTING (THERE IS A 5 YEAR VESTING PERIOD FOR THE AWARD, AND AWARDS FURTHER DO NOT VEST EVEN DURING THIS 5 YEAR PERIOD TO THE EXTENT THAT A LIQUIDITY EVENT SHALL NOT HAVE YET OCCURRED). THERE ARE VERY LIMITED EXCEPTIONS FOR RETIREMENT, DEATH AND DISABILITY. - THE RISK THAT THE PROCEEDS OF A LIQUIDITY EVENT WILL FAIL TO EXCEED PREDETERMINED COST REIMBURSEMENT HURDLES THAT ARE BUILT INTO EACH AWARD AGREEMENT. - THE RISK THAT THE UNDERLYING PROJECT OR SPINOUT COMPANY FAILS TO ACHIEVE A LIQUIDITY EVENT AT ALL. - THERE ARE ANNUAL AND CUMULATIVE CAPS TO THE PAYMENT OF AWARDS UNDER THE AWARD AGREEMENT. - RESTRICTIONS SET FORTH IN EACH AWARD AGREEMENT LIMIT THE MAXIMUM AMOUNT OF PROCEEDS TO WHICH A RECIPIENT'S AWARD PERCENTAGE WILL APPLY. THE PLAN AND EACH AWARD AGREEMENT WERE APPROVED BY THE BOARD OF DIRECTORS AFTER REVIEWING DETAILED COMPENSATION ANALYSIS INFORMATION PREPARED BY AN INDEPENDENT FIRM AND RECEIVING OUTSIDE LEGAL ADVICE, BOTH RELATING TO THE REASONABLENESS OF THE LTIP COMPENSATION. THE LTIP REQUIRES THAT THIS COMPENSATION ANALYSIS BE UPDATED EVERY TWO YEARS, AND THIS WAS DONE IN 2016, 2018 AND MOST RECENTLY IN 2020. IN THE 2020 ANALYSIS, THE COMPENSATION OF THE EXECUTIVE CHAIRMAN WAS ALSO PERFORMED. THE FOREGOING DESCRIPTIONS ARE QUALIFIED BY REFERENCE TO THE ACTUAL PLAN AND RELATED AWARD AGREEMENTS.ExplanationTxt

Schedule N IRS990ScheduleN

Disposition Of Assets Detail DispositionOfAssetsDetail (2 entries)

Assets Distri Or Expnss PaidAssetsDistriOrExpnssPaidDescDistributionDistributionDtFair Market Value Of AssetFairMarketValueOfAssetAmtMethod Of FMV DeterminationMethodOfFMVDeterminationTxt
MONOLYTHIX, INC.2020-03-26$5,364,195ACTUAL COST
MEDALLION THERAPEUTICS, INC.2019-12-09$30,901,152ACTUAL COST
FieldValueIRS element (for citing)
Director Of Successor20DirectorOfSuccessor2Ind
Employee Of Successor20EmployeeOfSuccessor2Ind
Owner Of Successor20OwnerOfSuccessor2Ind
Receive Compensation20ReceiveCompensation2Ind

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSCHEDULE N, PART IIFormAndLineReferenceDesc
ExplanationIN DECEMBER 2019, THE FOUNDATION DISSOLVED MEDALLION THERAPEUTICS, INC. ALL ASSETS AND LIABILITIES OF THE ENTITY WERE TRANSFERRED TO THE FOUNDATION IN ACCORDANCE WITH THE DISSOLUTION. IN JANUARY 2020, MONOLYTHIX, INC. SOLD CERTAIN INTELLECTUAL PROPERTY AND FIXED ASSETS TO AN UNRELATED THIRD-PARTY ENTITY IN EXCHANGE FOR A NOTE RECEIVABLE AND A MINORITY EQUITY INTEREST IN THE THIRD-PARTY ENTITY. SUBSEQUENT TO THIS SALE, MONOLYTHIX, INC. WAS DISSOLVED BY THE FOUNDATION AND ANY REMAINING ASSETS AND LIABILITIES WERE TRANSFERRED TO THE FOUNDATION.ExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (6 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FORM 990, PART VI, SECTION A, LINE 4ARTICLE VII OF THE AMENDED AND RESTATED ARTICLES OF INCORPORATION OF THIS CORPORATION IS AMENDED TO READ AS FOLLOWS: THE PROPERTY OF THIS CORPORATION IS IRREVOCABLY DEDICATED TO CHARITABLE AND SCIENTIFIC PURPOSES MEETING THE REQUIREMENTS OF CALIFORNIA REVENUE AND TAXATION CODE SECTION 214. UPON THE DISSOLUTION OR WINDING UP OF THIS CORPORATION, AFTER PAYING OR ADEQUATELY PROVIDING FOR THE DEBTS AND OBLIGATIONS THEREOF, ANY REMAINING ASSETS SHALL BE DISTRIBUTED, FOR USE IN FURTHERANCE OF THE PURPOSES OF THIS CORPORATION AS SET FORTH ABOVE IN THOSE ARTICLES OF INCORPORATION TO ONE OR MORE NONPROFIT FUNDS, FOUNDATIONS OR CORPORATIONS, WHICH ARE THEN IN EXISTENCE, WHICH ARE ORGANIZED AND OPERATED EXCLUSIVELY FOR CHARITABLE AND SCIENTIFIC PURPOSES MEETING THE REQUIREMENTS OF REVENUE AND TAXATION CODE SECTION 214, AND WHICH HAVE ESTABLISHED THEIR TAX EXEMPT STATUS A SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE OF 1986 AS AMENDED (OR ANY CORRESPONDING PROVISION OF FUTURE UNITED STATES INTERNAL REVENUE LAW).
FORM 990, PART VI, SECTION B, LINE 11BA DRAFT OF THE 990 WILL BE PRESENTED BY MANAGEMENT TO THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS FOR THEIR REVIEW AND DISCUSSION. A FULL COPY OF THE FORM WILL BE PROVIDED TO ALL VOTING MEMBERS PRIOR TO FILING WITH THE IRS.
FORM 990, PART VI, SECTION B, LINE 12CCONFLICT OF INTEREST DISCLOSURES ARE UPDATED ANNUALLY AND POTENTIAL CONFLICTS ARE REVIEWED PRIOR TO PARTICIPATING IN TRANSACTIONS. IF A CONFLICT EXISTS, THE PERSON WITH A CONFLICT DOES NOT VOTE.
FORM 990, PART VI, SECTION B, LINE 15THE BOARD OF DIRECTORS REVIEWS AND APPROVES THE COMPENSATION OF THE CEO AND HIS DIRECT REPORTS INCLUDING THE CFO. THEY ALSO REVIEW AND APPROVE THE OVERALL ANNUAL ADJUSTMENTS TO COMPENSATION OF OTHER EMPLOYEES. SPECIFIC ADJUSTMENTS FOR OTHER EMPLOYEES ARE HANDLED BY THE CEO AND HEAD OF HUMAN RESOURCES USING COMPARISONS TO SALARY SURVEYS FOR SIMILAR POSITIONS AND EXPERIENCE. THE BOARD OF DIRECTORS APPROVED COMPENSATION FOR THE CEO AND HIS DIRECT REPORTS INCLUDING THE CFO AND THE EXECUTIVE CHAIRMAN, ON 4/09/20. THIS PROCESS WAS DOCUMENTED.
FORM 990, PART VI, SECTION C, LINE 19MEMBERS OF THE PUBLIC OR INTERESTED PARTIES MAY REQUEST TO REVIEW OR RECIEVE A COPY OF THE GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS BY PHONE OR MAIL.
FORM 990, PART XI, LINE 9:DISSOLUTION OF MEDALLION -29,281,859. DISSOLUTION OF MONOLYTHIX -3,143,219.

Schedule R IRS990ScheduleR

Id Related Org Txbl Corp Tr IdRelatedOrgTxblCorpTrGrp (2 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdEINEINPrimary ActivitiesPrimaryActivitiesTxtLegal Domicile StateLegalDomicileStateCdBusiness Name Line1DirectControllingEntityName/BusinessNameLine1TxtEntity TypeEntityTypeTxtShare Of Total IncomeShareOfTotalIncomeAmtShare Of EOY AssetsShareOfEOYAssetsAmtOwnershipOwnershipPctControlled OrganizationControlledOrganizationInd
MONOLYTHIX INC
25134 RYE CANYON LOOPVALENCIACA91355464616473MONOLITHIC STRUCTURE DEVELOPMENT FOR DISEASE DETECTION, BLOOD ANALYSIS, ANDNVALFRED E MANN FOUNDATION FOR SCIENTIFIC RESEARCHC-$79,998$22,2800.73530Yes (1)
MEDALLION THERAPEUTICS INC
25134 RYE CANYON LOOPVALENCIACA91355464651082DEVELOPMENT AND COMMERCIALIZATION OF MEDICAL DEVICE (IMPLANTABLE DRUG PUMP)DEALFRED E MANN FOUNDATION FOR SCIENTIFIC RESEARCHC-$17,692,318Yes (1)
FieldValueIRS element (for citing)
Receipt Of Int Annts Rnts RyltsYes (1)ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth Org0GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth Org0GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other OrgYes (1)LoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth Org0LoansOrGuaranteesFromOthOrgInd
Div Related Organization0DivRelatedOrganizationInd
Asset Sale To Other Org0AssetSaleToOtherOrgInd
Asset Purchase From Other Org0AssetPurchaseFromOtherOrgInd
Asset Exchange0AssetExchangeInd
Rental Of Facilities To Oth Org0RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth Org0RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth Org0PerformOfServicesForOthOrgInd
Perform Of Services By Other Org0PerformOfServicesByOtherOrgInd
Sharing Of FacilitiesYes (1)SharingOfFacilitiesInd
Paid Employees SharingYes (1)PaidEmployeesSharingInd
Reimbursement Paid To Other Org0ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other OrgYes (1)ReimbursementPaidByOtherOrgInd
Transfer To Other Org0TransferToOtherOrgInd
Transfer From Other OrgYes (1)TransferFromOtherOrgInd

Transactions Related Org TransactionsRelatedOrgGrp (4 entries)

Transaction TypeTransactionTypeTxtInvolvedInvolvedAmtMethod Of Amount DeterminationMethodOfAmountDeterminationTxt
MONOLYTHIX INC
A$24,238LOAN
MONOLYTHIX INC
D$24,238INTEREST INCOME
MONOLYTHIX INC
S$1,073,593FMV
MEDALLION THERAPEUTICS INC
S$2,064,562APPRAISAL

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.